Moderna CEO Stéphane Bancel testifies at 10:00 a.m. ET on March 21 to U.S. Senate Health Committee on “Taxpayers Paid Billions For It: So Why Would Moderna Consider Quadrupling the Price of the COVID Vaccine?” Christopher J. Morten, associate clinical professor of Law at Columbia Law School; Dr. Ameet Sarpatwari, assistant professor of Medicine at…

Moderna CEO Stéphane Bancel testifies at 10:00 a.m. ET on March 21 to U.S. Senate Health Committee on “Taxpayers Paid Billions For It: So Why Would Moderna Consider Quadrupling the Price of the COVID Vaccine?” Christopher J. Morten, associate clinical professor of Law at Columbia Law School; Dr. Ameet Sarpatwari, assistant professor of Medicine at…

Moderna CEO Stéphane Bancel testifies at 10:00 a.m. ET on March 21 to U.S. Senate Health Committee on “Taxpayers Paid Billions For It: So Why Would Moderna Consider Quadrupling the Price of the COVID Vaccine?” Christopher J. Morten, associate clinical professor of Law at Columbia Law School; Dr. Ameet Sarpatwari, assistant professor of Medicine at…

Many younger people may not need COVID-19 boosters, the CEO of Moderna said on Oct. 17. “I think it’s going to be like the flu. If you’re a 25-year-old do you need an annual booster every year if you’re healthy?” Moderna CEO Stephane Bancel said during a Yahoo Finance event. “You might want it because…

Moderna Inc.’s vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Monday. “The vaccine is being finished … it should be in the clinic in coming weeks. We are…

Moderna CEO Stéphane Bancel said in an interview published on Tuesday that he predicts current COVID-19 vaccines will be far less effective against the Omicron variant due to the high number of mutations on the spike protein. “There is no world, I think, where [the effectiveness] is the same level … we had with Delta,” Bancel…

Moderna CEO Stéphane Bancel said in an interview published on Tuesday that he predicts current COVID-19 vaccines will be far less effective against the Omicron variant due to the high number of mutations on the spike protein. “There is no world, I think, where [the effectiveness] is the same level … we had with Delta,” Bancel…